InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Babu Yarlagadda S, Officier. Officer active across 1 company, notably Biocryst Pharmaceuticals INC. In total, 6 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €316k. History available since 7 December 2021. The latest transaction was disclosed on 14 November 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Babu Yarlagadda S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 shares@ US$1.427.6% of flowCommon StockSEC:0001127602-22-025761:0
20,000 shares@ US$17.1649.0% of flowCommon StockSEC:0001127602-22-008780:0
35,000 shares0Common StockSEC:0001127602-21-031134:0
62,000 shares@ US$4.7340.3% of flowCommon StockSEC:0001127602-21-030610:0
4,724 sharesCommon StockSEC:0001127602-16-037578:0
1,639 sharesCommon StockSEC:0001127602-16-035659:0
6 of 6 declarations
About Babu Yarlagadda S
Babu Yarlagadda S is an officer at Biocryst Pharmaceuticals INC, where the listed role is Chief Discovery Officer. He has 6 filings in total, and across the sampled recent filings the period runs from 2016-01-05 to 2022-11-16, with EUR 315600 of sales and EUR 0 of purchases; the most frequent transaction nature is Levée d'options.
